Premium
Healthcare-focused private equity firm InvAscent is investing in the bulk-drugs subsidiary of a Mumbai-listed company to......
This is a Premium article. Please subscribe or log in to read the full story!
Here's a selection of our recent premium content.
Already a member? Click here to log in.